CN115350330B - Application of electronegative micromolecule regulated surface in protein differential adhesion - Google Patents

Application of electronegative micromolecule regulated surface in protein differential adhesion Download PDF

Info

Publication number
CN115350330B
CN115350330B CN202211063100.XA CN202211063100A CN115350330B CN 115350330 B CN115350330 B CN 115350330B CN 202211063100 A CN202211063100 A CN 202211063100A CN 115350330 B CN115350330 B CN 115350330B
Authority
CN
China
Prior art keywords
substrate
electronegative
adhesion
protein
differential adhesion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202211063100.XA
Other languages
Chinese (zh)
Other versions
CN115350330A (en
Inventor
徐福建
杨雪
胡杨
付豪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing University of Chemical Technology
Original Assignee
Beijing University of Chemical Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing University of Chemical Technology filed Critical Beijing University of Chemical Technology
Priority to CN202211063100.XA priority Critical patent/CN115350330B/en
Publication of CN115350330A publication Critical patent/CN115350330A/en
Application granted granted Critical
Publication of CN115350330B publication Critical patent/CN115350330B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/222Gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/04Metals or alloys
    • A61L27/042Iron or iron alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/34Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/18Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00Materials or methods for coatings medical devices
    • A61L2420/02Methods for coating medical devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The invention discloses an application of a surface regulated by electronegative micromolecules to protein differential adhesion, which is characterized in that a substrate with cations on the surface is regulated by soaking electronegative micromolecule solution, so that differential adhesion of the surface of the substrate to different proteins can be realized, and the specific steps are as follows: preparing electronegative micromolecular solution; immersing a substrate with cations on the surface into electronegative micromolecular solution; washing and drying to obtain a modified substrate; the substrate differentially adheres to the protein. The electropositivity of the cationic polymer on the surface of the substrate is regulated and controlled through electronegative micromolecules so as to regulate and control the adhesion force of electropositive to electronegative proteins and realize regulation and control of protein adhesion amount and differential adhesion of different proteins.

Description

Application of electronegative micromolecule regulated surface in protein differential adhesion
Technical Field
The invention belongs to the technical field of preparation of medical materials, and relates to application of a electronegative micromolecule regulated surface to protein differential adhesion.
Background
In the field of tissue engineering, the selective adhesion of cells on the surface of a material has a very important meaning, and the selective adhesion is beneficial to simulating/remodelling the tissue structure of ordered combination of multiple types of cells in the original complex tissues of an organism. However, in the existing material preparation technology, cell selective adhesion depends on the preparation of material surfaces modified by biofunctional molecules (such as RGD, VEGF, and the like, nool s., et al acta biomatter.2016, 37,69), and the mechanism of action is that biofunctional molecules can mediate differential adhesion with different cell surface protein receptors, but the method depends on expensive biofunctional molecule preparation and biofunctional molecule surface fixing process which is unfavorable for mass production, and can only solve selective adhesion of a few cells with definite targets. Meanwhile, the high polymer material is flexible and various in structural design, is widely studied in the fields of tissue engineering, drug carriers and the like, can realize protein differential adhesion through fine structural design, and is also expected to further optimize the material structure so as to realize selective adhesion of cells. However, the current polymer material preparation technology is mainly focused on the research of cationic polymers (broad-spectrum enhanced protein/cell adhesion) and two materials of polyethylene glycol, electronegative polymers and zwitterionic polymers (obviously reduced protein/cell adhesion). Therefore, the preparation technology for simply and conveniently preparing the protein differential adhesion material is still lacking, and the development of the cell selective adhesion material in the field of tissue engineering is severely restricted.
Disclosure of Invention
In view of the above, the invention provides an application of electronegative small molecule controlled surface in differential adhesion of proteins. The technical scheme is specifically as follows: the application of the surface regulated by electronegative small molecules on the protein differential adhesion regulates and controls a substrate with cations on the surface by soaking electronegative small molecule solution, so that the differential adhesion of the surface of the substrate to different proteins can be realized, and the specific steps are as follows:
1) Preparing electronegative micromolecular solution;
2) Immersing the substrate with the cations on the surface into the solution in the step 1);
3) Washing and drying to obtain a modified substrate;
4) The substrate differentially adheres to the protein.
Further, the electronegative micromolecules in the step 1) are one or more of sodium methyl sulfate, sodium methyl sulfonate, N-cyclohexyl sodium sulfamate, morpholine ethane sulfonic acid sodium salt monohydrate, 3-N (-morpholino) propane sulfonic acid sodium, 3-morpholine-2-hydroxy propane sulfonic acid sodium and gluconic acid, and the concentration of the electronegative micromolecule solution is 0.5-50mg/mL.
Further, the proteins are albumin, globulin and fibrin.
Further, the substrates having cations on the surfaces thereof have three types:
the substrate a is a cation immobilization substrate obtained by self-assembling a substrate which does not contain cations on the surface and a cationic polymer;
the substrate b is a surface cation immobilization substrate obtained by chemical reaction of a substrate which does not contain cations on the surface and electropositive small molecules;
the substrate c is a substrate which contains a large amount of cationic groups on the surface, and the cationic groups are one or a combination of a plurality of guanidine groups, primary amines, quaternary amines or tertiary amines.
Further, the self-assembly in the substrate a is to coat the cationic polymer and the electronegative polymer on the surface by a layer-by-layer self-assembly method, and the outermost layer is controlled to be the cationic polymer.
Further, the substrate in the substrate a, which does not contain cations on the surface, is 304 stainless steel, metal titanium nails, silicon wafers, gelatin sponge, polyvinyl alcohol sponge or medical collagen sponge.
Further, the cationic polymer in the base material a is one or more of polydiallyl dimethyl ammonium chloride, poly (N, N-dimethylaminoethyl methacrylate), polylysine, polyhexamethylene biguanidine hydrochloride and polyhexamethylene monoguanidine hydrochloride, and the electronegative polymer is one or more of poly (4-sodium styrene sulfonate) and polymethacrylic acid.
Further, the substrate in the substrate b, which does not contain cations on the surface, is gelatin sponge, polyvinyl alcohol sponge, medical collagen sponge or gauze.
Further, the chemical reaction in the substrate b is a quaternization reaction, and a ring-opening reaction is carried out between hydroxyl, amino or carboxyl on the substrate surface without cations on the substrate surface and the quaternary ammonium salt containing epoxy groups; the quaternary ammonium salt containing epoxy group is 2, 3-epoxypropyl trimethyl ammonium chloride or a product obtained by reacting epoxy chloropropane with N, N-dimethyl X amine, and X is B, C and T.
Further, the method is characterized in that after 2, 3-epoxypropyl trimethyl quaternary ammonium salt modified gelatin and sodium methyl sulfate are soaked, the gelatin can be used for high adhesion of fibrinogen, albumin, globulin and the like; the cationic immobilized 304 stainless steel surface obtained by alternately self-assembling and modifying poly (4-styrene sodium sulfonate) and poly (diallyl dimethyl ammonium chloride) and sodium methyl sulfate can be used for high adhesion to globulin and low adhesion to fibrin after being soaked.
The invention has the beneficial effects that: according to the protein differential adhesion surface material regulated by electronegative micromolecules, a part of counter anions (such as hydroxide, chloride ions and the like) are converted into newly introduced electronegative micromolecules through the competitive action of the electronegative micromolecules and the original counter anions of the cationic polymer, so that the ferroelectric property (and the accompanying strong binding capacity/adhesion force with electronegative proteins) of the cationic polymer on the surface of a substrate is regulated, and finally the regulation of the protein adhesion amount and the differential adhesion of different proteins are realized. Therefore, compared with the direct chemical synthesis, the invention realizes the polymer structure design and the protein adhesion regulation (the chemical synthesis is often fine but complicated), and provides a simpler and more convenient method for preparing the protein differential adhesion material.
Detailed Description
A preferred embodiment of the present invention will be described in detail.
Example 1
1) 300mg of sodium hydroxide is dissolved in 10mL of deionized water, 1200mg of 2, 3-epoxypropyl trimethyl quaternary ammonium salt (GTA) is dissolved in 40mL of deionized water, the two are mixed to soak the gelatin sponge for 24 hours, the deionized water is washed for 3 times each for 10 minutes, and the Quaternized Gelatin Sponge (QGS) is obtained through freeze drying.
2) The quaternized gelatin sponge in the step 1) is soaked in 10mg/mL sodium methyl sulfate aqueous solution for 2 hours, washed with deionized water for 3 times each for 30 minutes, and freeze-dried to obtain hemostatic sponge X1.
In this example, the surface is provided with a cationic substrate which is a quaternized gelatin sponge, and the cationic polymer is a quaternized gelatin, and the electronegative small molecule is sodium methyl sulfate.
Example 2
The quaternized gelatin sponge in the step 1) in the example 1 is soaked in 21mg/mL sodium methyl sulfate aqueous solution for 2 hours, washed with deionized water for 3 times each for 30 minutes, and freeze-dried to obtain hemostatic sponge X2.
In this example, the concentration of electronegative small molecule sodium methyl sulfate was different from that in example 1.
Example 3
1) 304 stainless steel sheet (S for short) is cut into 1X 1cm 2 Continuously ultrasonic cleaning with isopropanol, ethanol and water, drying, and treating with oxygen plasma. 1mg/mL of poly (diallyldimethylammonium chloride) (PDADMAC) solution and 1mg/mL of poly (sodium 4-styrenesulfonate) (PSS) solution were prepared with deionized water. Alternately soaking PDADMAC and PSS solution for 20min each time, washing with deionized water for 1min, and blowing nitrogen for 2min to obtain S-PP 4.5 (S-PP 4.5 The outermost layer is the cationic polymer polydiallyl dimethyl ammonium chloride
2) S-PP as in 1) 4.5 Soaking in 0.1mg/mL sodium methyl sulfate aqueous solution for 1h, washing with deionized water for 1 time, each time for 1min, and drying with nitrogen to obtain hemostatic material X3.
In this example, the surface provided with the cationic substrate was a cationic immobilized substrate S-PP obtained by alternately self-assembling a 304 stainless steel sheet with poly (4-styrenesulfonate sodium) and poly (diallyldimethylammonium chloride) 4.5 The cationic polymer is poly (diallyl dimethyl ammonium chloride), and the electronegative small molecule is sodium methyl sulfate.
Comparative example 1
The quaternized gelatin sponge obtained in step 1) of example 1 was designated Y1.
Comparative example 2
Unmodified gelatin sponge, designated Y2.
Comparative example 3
Unmodified 304 stainless steel sheet, designated Y3.
Test example 1 protein adhesion test
The prepared protein differential adhesion surface materials X1-X3 and the comparative examples Y1-Y3 are subjected to adhesion test and comparative experiments of albumin, globulin and fibrinogen.
The testing method comprises the following steps: taking a test method of human albumin as an example, adding 3mg of gelatin sponge series materials into a 2mL centrifuge tube, and taking 1X 1cm stainless steel sheets before and after modification 2 The mixture was placed in a 6-well plate. Human albumin was prepared as a 10mg/mL PBS solution, 50. Mu.L of the protein solution was added to the material and incubated in a constant temperature water bath at 37℃for 30 minutes. Excess liquid was aspirated off, and 200. Mu.L PBS was usedThe solution is lightly washed for 1 washing, the volume of the washing solution is fixed to 500 mu L, 50 mu L of the washing solution is taken in a 2mL centrifuge tube, 1mL of BCA working solution (reagent A: reagent B=50:1 (v/v)) prepared in advance is added, the solution is placed in a constant temperature water bath at 37 ℃ for incubation for 30 minutes, 100 mu L of the solution is taken and added into a 96-well plate, and absorbance Abs at 562nm is tested.
Blank 50. Mu.L of protein solution was added to a 2mL centrifuge tube. The control group was material plus 50 μl PBS.
Protein adhesion rate η% = (1- (Abs sample-Abs control)/Abs blank) ×100%
The albumin adhesion rates of the examples and comparative examples are shown in table 1:
TABLE 1 Albumin adhesion test results
Sample of X1 X2 Y1 Y2
η(%) 8.9 6.8 8.1 2.0
The globulin adhesion rates of the examples and comparative examples are shown in table 2:
TABLE 2 results of globulin adhesion Rate test
Sample of X1 X2 X3 Y1 Y2 Y3
η(%) 9.5 11.1 7.9 8.6 3.1 6.0
The fibrinogen adhesion rates of the examples and comparative examples are shown in Table 3:
TABLE 3 fibrinogen adhesion test results
Sample of X1 X2 X3 Y1 Y2 Y3
η(%) 31.0 14.6 3.9 10.5 6.0 10.1
The protein adhesion rate is an important index for representing the protein adhesion effect on the surface of the material, and the larger the adhesion percentage is, the better the protein adhesion performance of the material is.
As can be seen from the data of tables 1 to 3, the gelatin sponge of examples 1 to 2 of the present invention (gelatin sponge material having a 12% protein adhesion rate as high protein adhesion property) X1 achieves high adhesion to fibrinogen while moderate adhesion to albumin and globulin; x2 achieves high adhesion to fibrinogen while medium adhesion to albumin and globulin.
As can be seen from the data of tables 1 to 3, the stainless steel sheet of inventive example 3 (the surface of the metal material had a protein adhesion rate of 6% as a medium/acceptable protein adhesion property) X3 achieved high adhesion to globulin while the adhesion to fibrinogen was low.
Therefore, by adopting the preparation method, the electropositivity of the cationic polymer can be effectively regulated by soaking electronegative small molecules with different concentrations, and the regulation of the protein adhesion amount and the selective adhesion of different proteins can be realized by regulating and controlling the strong adhesion acting force of the electropositivity to electronegative proteins. The specific analysis is as follows:
comparative example 1 is a gelatin sponge with a surface immobilized with a cationic polymer, and the adhesion rate to all three proteins is improved compared with comparative example 2 (unmodified gelatin sponge), which shows that the positive ion is positively adhered to negative protein, and the sponge Y1 obtained in comparative example is broad-spectrum and high-adhesion without selectivity to protein.
The protein adhesion rate data of examples 1-2 and comparative example 1 (gelatin sponge with surface immobilized with cationic polymer) shows that the adhesion rate of sponge X1 to albumin and globulin is substantially unchanged (adhesion rates from 8.1% to 8.9%, from 8.6% to 9.5%, respectively) and the adhesion rate to fibrinogen is increased (adhesion rate increases from 10.5% to 31.0%) when small molecules are added to form a complex system; the adhesion rate of sponge X2 to albumin was low (adhesion rate was reduced from 8.1% to 6.8%) and to globulin and fibrinogen was high (adhesion rates were increased from 8.6% to 11.1% and from 10.5% to 14.6%, respectively). Thus, the sponge prepared by the invention can realize differential adhesion to protein.
The protein adhesion rate data of example 3 and comparative example 3 (unmodified 304 stainless steel sheet) shows that the adhesion rate of stainless steel sheet X3 to globulin becomes high (the adhesion rate increases from 6.0% to 7.9%) and the adhesion rate to fibrinogen decreases (the adhesion rate decreases from 10.1% to 3.9%) when a composite system is formed by adding small molecules and cationic polymer. Thus, the membrane prepared by the invention can realize differential adhesion to protein.
Finally, it is noted that the above-mentioned preferred embodiments are only intended to illustrate rather than limit the invention, and that, although the invention has been described in detail by means of the above-mentioned preferred embodiments, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the scope of the invention as defined by the appended claims.

Claims (7)

1. The application of the surface regulated by electronegative small molecules on the protein differential adhesion is characterized in that the substrate with cations on the surface is regulated by soaking electronegative small molecule solution, so that the differential adhesion of the substrate surface to different proteins can be realized, and the specific steps are as follows:
1) Preparing electronegative micromolecular solution;
2) Immersing the substrate with the cations on the surface into the solution in the step 1);
3) Washing and drying to obtain a modified substrate;
4) The base material carries out differential adhesion on the protein;
the electronegative micromolecules in the step 1) are one or more of sodium methyl sulfate, sodium methyl sulfonate, N-cyclohexyl sodium sulfamate, morpholine ethane sodium sulfonate monohydrate, 3-N (-morpholino) sodium propane sulfonate, 3-morpholine-2-hydroxy sodium propane sulfonate and gluconic acid, and the concentration of the electronegative micromolecule solution is 0.5-50 mg/mL;
the proteins are albumin, globulin and fibrin, and the differential adhesion is different adhesion rates after the mass contact;
the base material with cations on the surface has three types:
the substrate a is a cation immobilization substrate obtained by self-assembling a substrate which does not contain cations on the surface and a cationic polymer;
the substrate b is a surface cation immobilization substrate obtained by chemical reaction of a substrate which does not contain cations on the surface and electropositive small molecules;
the substrate c is a substrate which contains a large amount of cationic groups on the surface, and the cationic groups are one or a combination of a plurality of guanidine groups, primary amines, quaternary amines or tertiary amines.
2. The application of the electronegative small molecule controlled surface to protein differential adhesion according to claim 1, wherein the self-assembly in the substrate a is to coat the surface with a cationic polymer and an electronegative polymer by a layer-by-layer self-assembly method, and the outermost layer is controlled to be the cationic polymer.
3. The application of the electronegative micromolecule controlled surface to protein differential adhesion according to claim 1, wherein the substrate in the substrate a, which does not contain cations on the surface, is 304 stainless steel, metal titanium nails, silicon wafers, gelatin sponge, polyvinyl alcohol sponge or medical collagen sponge.
4. The application of the electronegative small molecule controlled surface to protein differential adhesion according to claim 2, wherein the cationic polymer in the substrate a is one or more of polydiallyl dimethyl ammonium chloride, poly (N, N-dimethylaminoethyl methacrylate), polylysine, polyhexamethylene biguanide hydrochloride and polyhexamethylene monoguanidine hydrochloride, and the electronegative polymer is one or more of poly (4-sodium styrene sulfonate) and polymethacrylic acid.
5. The application of the electronegative micromolecule controlled surface to protein differential adhesion according to claim 1, wherein the substrate which does not contain cations on the surface of the substrate b is gelatin sponge, polyvinyl alcohol sponge, medical collagen sponge or gauze.
6. The application of the electronegative small molecule controlled surface to the differential adhesion of proteins according to claim 1, wherein the chemical reaction in the substrate b is a quaternization reaction, and the ring-opening reaction is carried out between hydroxyl, amino or carboxyl on the substrate surface without cations on the substrate surface and the quaternary ammonium salt containing epoxy groups; the quaternary ammonium salt containing epoxy group is 2, 3-epoxypropyl trimethyl ammonium chloride or a product obtained by reacting epoxy chloropropane with N, N-dimethyl X amine, and X is B, C and T.
7. The application of the electronegative micromolecule controlled surface to protein differential adhesion according to claim 1, wherein the application is characterized in that the differential adhesion to fibrinogen, albumin and globulin can be realized after 2, 3-epoxypropyl trimethyl quaternary ammonium salt modified gelatin and sodium methyl sulfate are soaked; after the cationic immobilized 304 stainless steel surface obtained by alternately self-assembling and modifying the poly (4-styrene sodium sulfonate) and the poly (diallyl dimethyl ammonium chloride) and the sodium methyl sulfate are soaked, the differential adhesion of the globulin and the fibrinogen can be realized.
CN202211063100.XA 2022-09-01 2022-09-01 Application of electronegative micromolecule regulated surface in protein differential adhesion Active CN115350330B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202211063100.XA CN115350330B (en) 2022-09-01 2022-09-01 Application of electronegative micromolecule regulated surface in protein differential adhesion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202211063100.XA CN115350330B (en) 2022-09-01 2022-09-01 Application of electronegative micromolecule regulated surface in protein differential adhesion

Publications (2)

Publication Number Publication Date
CN115350330A CN115350330A (en) 2022-11-18
CN115350330B true CN115350330B (en) 2023-10-20

Family

ID=84003891

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202211063100.XA Active CN115350330B (en) 2022-09-01 2022-09-01 Application of electronegative micromolecule regulated surface in protein differential adhesion

Country Status (1)

Country Link
CN (1) CN115350330B (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1283107A (en) * 1998-10-23 2001-02-07 伊迪亚股份公司 Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable De/association rates
CN103917221A (en) * 2011-11-11 2014-07-09 宝洁公司 Surface treatment compositions including shielding salts
CN104383609A (en) * 2014-11-07 2015-03-04 浙江大学 Material capable of regulating cell adhesion
CN105722500A (en) * 2013-09-11 2016-06-29 阿尔西亚治疗有限公司 Liquid protein formulations containing ionic liquids
CN111440242A (en) * 2020-04-01 2020-07-24 国家纳米科学中心 Anti-pollution polypeptide, nerve electrode modified by anti-pollution polypeptide, modification method and application
CN114306725A (en) * 2021-11-30 2022-04-12 南方科技大学 Single-sided adhesive hydrogel adhesive and preparation method and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018112282A1 (en) * 2016-12-14 2018-06-21 Ligandal, Inc. Compositions and methods for nucleic acid and/or protein payload delivery

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1283107A (en) * 1998-10-23 2001-02-07 伊迪亚股份公司 Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable De/association rates
CN103917221A (en) * 2011-11-11 2014-07-09 宝洁公司 Surface treatment compositions including shielding salts
CN105722500A (en) * 2013-09-11 2016-06-29 阿尔西亚治疗有限公司 Liquid protein formulations containing ionic liquids
CN104383609A (en) * 2014-11-07 2015-03-04 浙江大学 Material capable of regulating cell adhesion
CN111440242A (en) * 2020-04-01 2020-07-24 国家纳米科学中心 Anti-pollution polypeptide, nerve electrode modified by anti-pollution polypeptide, modification method and application
CN114306725A (en) * 2021-11-30 2022-04-12 南方科技大学 Single-sided adhesive hydrogel adhesive and preparation method and application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
《盐离子对蛋白质带电特性的影响》;刘春杰等;《原子与分子物理学报》;第38卷(第2期);第021005-1页至021005-8页 *

Also Published As

Publication number Publication date
CN115350330A (en) 2022-11-18

Similar Documents

Publication Publication Date Title
EP0347755B1 (en) Charge-modified hydrophobic membrane materials and method for making the same
US7094347B2 (en) Positively charged membrane
JP4152075B2 (en) A new method to adjust surface modifying substances
JP2685145B2 (en) Enzyme electrode
JP2009148276A (en) Highly volumetric method for separating, purifying, concentrating, fixing and synthesizing compound, and use based on the same
US7435594B2 (en) Scaffold for culturing cells
CN115337444B (en) Preparation method of electronegative micromolecule-regulated procoagulant surface
CN105601976B (en) A kind of method that antimicrobial surface is prepared in biomedical material surface
US5280078A (en) Homopolymers and copolymers of acrylamide N-substituted acrylamide or N-substituted methacrylamide solid state cross-linked with polyamines or polyols
CN115350330B (en) Application of electronegative micromolecule regulated surface in protein differential adhesion
US20080241942A1 (en) Air-stable supported lipid bilayer membranes
CN104060311A (en) Method for functionally modifying surface of conductive substrate
CN101568829A (en) Hemoglobin measurement method and electrophoresis apparatus
Popkov et al. Engineering polyelectrolyte multilayer coatings as a strategy to optimize enzyme immobilization on a membrane support
EP0240586B1 (en) Post-cross-linked polymeric gels
EP1352957A1 (en) Carriers for covalent immobilization of enzymes
CN115418031B (en) Preparation method and application of electronegative micromolecule/cationic polymer composite protein differential adhesion material
KR101195533B1 (en) A alpha-cyclodextrin derivative and polyelectrolyte multilayer comprising alpha-cyclodextrin derivative layer
JP3981598B2 (en) Ion exchange membrane
CN106905554B (en) A method of the phosphoryl choline polymer containing amino and the density of glutaraldehyde bionic coating
KR101190267B1 (en) A beta-cyclodextrin derivative and polyelectrolyte multilayer comprising beta-cyclodextrin derivative layer
JPH04183392A (en) Production of membrane immobilizing physiologically active substance
JP2003304868A (en) Polypeptide-containing substrate
CN115350319A (en) Preparation method of electronegative micromolecule-regulated cationic polymer-based hemostatic material
JP7495766B1 (en) Method for hydrophilizing substrate and hydrophilically modified substrate

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant